IN THE UNITED STATES PATENT AND TRADEMARK
In re application of:
SEBBEL et al.
Appl. No. 09/848,616 /
Filed: May 4, 2001
For: Molecular Antigen Array
Confirmation No.: 6018
Art Unit: 1648
Examiner: Mosher, M.
Atty. Docket: 1 700.0 1 80002/JAG/B JD
Amendment and Reply Under 37 C.F.R. §§ 1.111 and 1.121
Commissioner for Patents RECEIVED
P.O. Box 1450 U
Alexandria, VA 22313-1450 A(JG 1 ^
sir: TECH CENTER 1600/2900
In reply to the Office Action dated February 7, 2003 (Paper No. 11), Applicants
submit the following Amendment and Remarks, hi accordance with 37 C.F.R. § 1.121, this
Amendment is provided in the following format:
(A) Each section begins on a separate sheet;
(B) Starting on a separate sheet, a complete listing of all the claims:
in ascending order;
with status identifiers; and
* - with markings in the currently amended claims; and
(C) Starting on a separate sheet, the Remarks.
It is not believed that extensions of time or fees for net addition of claims are required
beyond those that may otherwise be provided for in documents accompanying this paper.
However, if additional extensions of time are necessary to prevent abandonment of this
08/08/2003 STEUMEL1 00000024 09848&16
- 2 - SEBBEL et al.
Appl. No. 09/848,616
application, then such extensions of time are hereby petitioned under 37 C.F.R. § 1.136(a),
and any fees required therefor (including fees for net addition of claims) are hereby
authorized to be charged to our Deposit Account No. 19-0036.